Back    Zoom +    Zoom -
<Research>BofAS Lifts ALI HEALTH (00241.HK) TP to $5.2, Expects 2HFY2025 Rev. Growth to Accelerate
Recommend
19
Positive
25
Negative
13
BofA Securities issued a research report maintaining its results forecasts for FY2025 ended March 2025 for ALI HEALTH (00241.HK), which are higher than the market consensus and the Company's guidance.

Of which, revenue is expected to grow 13% YoY, ahead of market forecasts and company guidance of a hike of 12%/ over 10% respectively.

Related NewsBOCI Lists Actively-traded Stocks for CN-HK Southbound Link YTD (Table)
BofA Securities estimated ALI HEALTH's revenue to accelerate from a 10% YoY incline in 1HFY2025 ended September 2024 to a 15% YoY growth in 2HFY2025 ended March 2025, close to the 16% rise forecast of its peer, JD HEALTH (06618.HK).

Therefore, the broker lifted its target price on ALI HEALTH from $4.6 to $5.2, with rating reiterated at Buy.
AAStocks Financial News